ARVN vs REGN: Which Stock is Better?
Side-by-side comparison of Arvinas Inc and Regeneron Pharmaceuticals Inc in 2026
ARVN
Arvinas Inc
$8.98
REGN
Regeneron Pharmaceuticals Inc
$614.78
Key Metrics Comparison
| Metric | ARVN | REGN | Winner |
|---|---|---|---|
| Market Cap | $579.40M | $64.45B | REGN |
| P/E Ratio | N/A | 15.02 | REGN |
| EPS (TTM) | $N/A | $40.94 | REGN |
| Revenue Growth | -0.9% | 0.2% | REGN |
| Gross Margin | 134.5% | 43.9% | ARVN |
Analyze ARVN
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARVN or REGN a better investment?
Comparing ARVN and REGN: Arvinas Inc has a market cap of $579.40M while Regeneron Pharmaceuticals Inc has $64.45B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARVN and REGN?
ARVN (Arvinas Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARVN or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARVN or REGN?
REGN has higher revenue growth at 0.2% vs -0.9% for ARVN.
Which company is more profitable: ARVN or REGN?
Arvinas Inc (ARVN) has higher gross margins at 134.5% compared to 43.9% for REGN.
Which is the larger company: ARVN or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $64.45B compared to $579.40M for ARVN.
Should I buy ARVN or REGN in 2026?
Both ARVN and REGN have investment merit. ARVN trades at $8.98 while REGN trades at $614.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARVN and REGN stock?
Key differences: Market Cap ($579.40M vs $64.45B), P/E Ratio (N/A vs 15.0x), Revenue Growth (-0.9% vs 0.2%), Gross Margin (134.5% vs 43.9%).